Pharmalot Ed Silverman STAT Plus: U.S. Supreme Court to review controversial Purdue Pharma bankruptcy settlement
Letters to the editor Torie Bosch What STAT readers think about premed requirements, too much health care, harm reduction, and more
Health tech Lizzy Lawrence STAT Plus: A digital pill shows early promise in detecting opioid overdose, sleep apnea
Politics Lev Facher STAT Plus: To fight bias against people with addiction, White House calls for ‘recovery-friendly’ workplaces
Politics Rachel Cohrs and Sarah Owermohle STAT Plus: Republicans divided over financial crisis in Medicare
Politics Lev Facher STAT Plus: Senate bill would permanently extend Covid-era rules on telehealth addiction treatment
First Opinion Ed Bisch I lost my son to OxyContin. ‘The Fall of the House of Usher’ is my Sackler revenge fantasy
Politics John Wilkerson and Rachel Cohrs STAT Plus: Senate committee plans Nov. 8 vote on wide-ranging health care package
Health Matt Stout — Boston Globe STAT Plus: Federal bill would keep addiction medication from triggering a child abuse investigation
Health tech Mario Aguilar STAT Plus: Pear’s shadow effect: Data from a Medicaid digital health experiment does the policy rounds
First Opinion Jacqueline Seitz STAT Plus: Where are HHS and the FTC on online privacy for people with substance use disorder?
Health Rachel Wisniewski Not yet free from heroin’s grip, an ‘honest, funny man’ finds his way off the streets
Health Lev Facher STAT Plus: Republicans say they’ll stop fentanyl at the border. But what are their plans for treatment?
Pharmalot Ed Silverman STAT Plus: Supreme Court blocks Purdue bankruptcy plan that would shield Sacklers from lawsuits
Health Bree Iskandar STAT Plus: His book on the opioid crisis flopped in 2003. It now has a new life on Netflix
Politics Simar Bajaj STAT Plus: Mental illness, drug addiction go hand in glove, Biden’s drug czar tells lawmakers
Health Lev Facher Providers still hesitate to prescribe buprenorphine for addiction, despite ‘X-waiver’ removal
Health Lev Facher White House announces new plan to address the growing threat of xylazine in overdose crisis
First Opinion Mitchell Berger What does it mean to be ‘in recovery’? We need a better federal definition